MENU
MDGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Madrigal Pharmaceuticals (MDGL) Earnings Date & Reports

A.I. Advisor
published Earnings

MDGL is expected to report earnings to fall 6.30% to -461 cents per share on February 26

Madrigal Pharmaceuticals MDGL Stock Earnings Reports
Q4'24
Est.
$-4.61
Q3'24
Beat
by $1.84
Q2'24
Beat
by $0.38
Q1'24
Missed
by $1.09
Q4'23
Missed
by $0.44
The last earnings report on October 31 showed earnings per share of -492 cents, beating the estimate of -676 cents. With 109.58K shares outstanding, the current market capitalization sits at 6.87B.
View a ticker or compare two or three
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com